These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32578259)

  • 1. Editorial Comment to Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma.
    Teishima J
    Int J Urol; 2020 Aug; 27(8):662. PubMed ID: 32578259
    [No Abstract]   [Full Text] [Related]  

  • 2. Contact with renal sinus is associated with poor prognosis in surgically treated pT1 clear cell renal cell carcinoma.
    Izumi K; Saito K; Nakayama T; Fukuda S; Fukushima H; Uehara S; Koga F; Yonese J; Kageyama Y; Fujii Y
    Int J Urol; 2020 Aug; 27(8):657-662. PubMed ID: 32458519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Editorial comment.
    Weight CJ
    Urology; 2009 Nov; 74(5):1068-9. PubMed ID: 19883823
    [No Abstract]   [Full Text] [Related]  

  • 4. Editorial comment to postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
    Nohara T
    Int J Urol; 2011 Jun; 18(6):477. PubMed ID: 21599761
    [No Abstract]   [Full Text] [Related]  

  • 5. [Renal cell carcinoma in the solitary kidney].
    Kagawa S; Takigawa H; Aga Y; Sumiyoshi Y; Imagawa A; Yuasa M; Numata A; Terao N
    Hinyokika Kiyo; 1988 Apr; 34(4):619-22. PubMed ID: 3400545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Editorial comment to cytoreductive nephrectomy for pT3b-T4 M1 renal cell carcinoma in 39 patients: single center analysis.
    O'Malley RL
    Int J Urol; 2012 Sep; 19(9):879-80. PubMed ID: 22672656
    [No Abstract]   [Full Text] [Related]  

  • 7. Editorial Comment to Partial nephrectomy versus radical nephrectomy for non-metastatic pathological T3a renal cell carcinoma: a multi-institutional comparative analysis.
    Eto M
    Int J Urol; 2014 Apr; 21(4):358. PubMed ID: 24118209
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial comment to "Predictors of benign histology in clinical T1a renal cell carcinoma tumors undergoing partial nephrectomy".
    Izumi K
    Int J Urol; 2014 Jan; 21(1):103. PubMed ID: 23634777
    [No Abstract]   [Full Text] [Related]  

  • 9. pT1 clear cell renal cell carcinoma: a study of the association between MIB-1 proliferative activity and pathologic features and cancer specific survival.
    Cheville JC; Zincke H; Lohse CM; Sebo TJ; Riehle D; Weaver AL; Blute ML
    Cancer; 2002 Apr; 94(8):2180-4. PubMed ID: 12001115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial comment to similar functional outcomes after partial nephrectomy for clinical T1b and T1a renal cell carcinoma.
    Miocinovic R; Simmons MN
    Int J Urol; 2012 Nov; 19(11):986-7. PubMed ID: 22835044
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial Comment: Role of preoperative MR volumetry in patients with renal cell carcinoma for prediction of postoperative renal function after radical nephrectomy and nephron sparing surgery.
    Favorito LA
    Int Braz J Urol; 2020; 46(2):242-243. PubMed ID: 32022513
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nephrectomy in kidney tumor following pyelolithotomy and extracorporeal lithotripsy for recurrence].
    Panchev P; Kirilov S; Neĭkov K
    Khirurgiia (Sofiia); 1989; 42(5):91-2. PubMed ID: 2625928
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial comment.
    Russo P
    Urology; 2011 Apr; 77(4):847-8. PubMed ID: 21477710
    [No Abstract]   [Full Text] [Related]  

  • 14. Editorial comment.
    Maranchie JK
    J Urol; 2010 Feb; 183(2):492. PubMed ID: 20006863
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial Comment to Peritumoral pseudocapsule status according to pathological characteristics from robot-assisted laparoscopic partial nephrectomy for localized renal cell carcinoma.
    Teishima J; Matsubara A
    Int J Urol; 2019 Apr; 26(4):450. PubMed ID: 30659662
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial Comment from Dr Kadono to Timing and distribution of early renal cell carcinoma recurrences stratified by pathological nodal status in M0 patients at the time of nephrectomy.
    Kadono Y
    Int J Urol; 2020 Jul; 27(7):623-624. PubMed ID: 32452086
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial comment.
    Huang WC
    Urology; 2011 Jul; 78(1):98. PubMed ID: 21712114
    [No Abstract]   [Full Text] [Related]  

  • 18. Editorial comment.
    Cost NG; Margulis V
    J Urol; 2011 Feb; 185(2):413; author reply 414. PubMed ID: 21168168
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial comment.
    Deane LA
    Urology; 2012 May; 79(5):1067; author reply 1067. PubMed ID: 22546385
    [No Abstract]   [Full Text] [Related]  

  • 20. Comment on "Mean platelet volume-to-lymphocyte ratio: a novel biomarker associated with overall survival in patients with nonmetastatic clear cell renal cell carcinoma treated with nephrectomy".
    Coban E
    Int Urol Nephrol; 2020 Sep; 52(9):1703. PubMed ID: 32206959
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.